BioSpace News Archive

IND filed for UCART22 clinical investigation in ALL patients Allogene takes over Pfizer’s rights under the Research and License Agreement with Cellectis, to accelerate development and commercialization of allogeneic off-the-shelf UCART therapies Harvard’s Wyss Institute partners with Cellectis to recode the human genome using TALEN® gene editing technology

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved DARZALEX® (daratumumab) in combination with VELCADE® (bortezomib).

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its active pharmaceutical ingredient (API) R&D and manufacturing facility located in Changzhou, China has secured Pre-Approval Inspection (PAI) for two APIs from the U.S. Food and Drug Administration (FDA) – with no Form 483s issued.

Brookdale Senior Living Inc. (NYSE: BKD) (“Brookdale” or the “Company”) announced results for the quarter ended March 31, 2018.

Advanced Biotechnologies introduces their new line of Quantitated Viral RNA products suitable for use in clinical labs and research facilities requiring RNA extracted from highly-purified virus.

Progress Update on INSPIRE 2.0 Trial, Finance Officer Appointment

Calyxt exceeds acre target for high-oleic soybean product launch, contracting over 16,000 acres for planting Planting of high-oleic soybean crop started High fiber wheat became Calyxt’s 7th product deemed non-regulated by USDA

Evolus, Inc. announced that its board of directors has named David Moatazedi as President and Chief Executive Officer.